A federal investigation into Hims & Hers Health has triggered a securities class action lawsuit, leaving investors reeling after a sharp stock decline. The litigation centers on allegations that the telehealth provider misled the public regarding data privacy and subscription billing practices, prompting a major sell-off of company shares.
Investors who purchased Honeywell Aerospace common stock between June 29 and September 1, 2026, face a November 23 deadline to seek lead plaintiff status in a federal class action. The lawsuit, filed in Arizona, accuses the company of misleading shareholders regarding supply chain vulnerabilities and government cybersecurity compliance.
Investors in York Space Systems have until October 30, 2026, to seek lead plaintiff status in a federal securities class action. The lawsuit, filed in the U.S. District Court for the District of Colorado, targets alleged misrepresentations surrounding the company’s satellite software functionality and defense contract performance following its January 2026 IPO.
Investors who purchased Beta Bionics stock between July 30, 2025, and February 24, 2026, are being urged to join a class action lawsuit. The legal challenge follows revelations that the company allegedly concealed thousands of safety complaints regarding its iLet insulin delivery system, misleading the market about the device's regulatory standing.
As home cooking routines settle into the autumn season, a European-funded initiative is looking to refresh U.S. pantries with a curated selection of exports. The Charming Taste of Europe campaign is promoting specific regional wines and fruits from Italy, Greece, and France to encourage more variety in everyday meal preparation.
The global protein expression market is set for sustained expansion, with valuations expected to climb from USD 3.50 billion in 2025 to USD 7.30 billion by 2034. A compound annual growth rate of 8.8% is fueling this trajectory, driven by intensifying demand for recombinant biologics and therapeutic protein development.
Shareholders of STAAR Surgical Company are under scrutiny as the law firm Levi & Korsinsky, LLP launches an investigation into potential breaches of fiduciary duty by the firm’s officers and directors. The inquiry focuses on whether corporate leadership failed to uphold their obligations to investors in the NASDAQ-listed medical device manufacturer.
The New York-based law firm Levi & Korsinsky has launched a formal investigation into Meridian Corporation regarding potential breaches of fiduciary duty by its officers and directors. The inquiry targets corporate governance standards at the NASDAQ-listed financial entity, inviting current shareholders to review their legal standing in the matter.
Shareholders of Arlo Technologies, Inc. are under scrutiny as the law firm Levi & Korsinsky, LLP launches an investigation into potential breaches of fiduciary duties by the company’s officers and directors. The inquiry centers on whether leadership failed in its legal obligations to investors during their tenure at the firm.
Shareholders of Onto Innovation Inc. are under scrutiny as New York-based law firm Levi & Korsinsky launched an investigation into potential breaches of fiduciary duty by the company’s directors and officers. The inquiry focuses on whether corporate leadership failed to uphold their obligations to the NYSE-listed firm's investors.
Investors holding shares in High Roller Technologies are under scrutiny by legal firm Levi & Korsinsky, which launched an investigation into potential fiduciary duty breaches by the company’s leadership. The firm is currently soliciting contact from shareholders as it examines governance practices at the New York-based entity.
Investors who purchased AppLovin shares between February 12 and August 5, 2026, are now seeking damages through a securities class action. The litigation centers on allegations that the company misled shareholders regarding the efficacy of its AI-driven advertising models, leading to a massive $44 billion wipeout in market valuation.
Kelowna-based Doseology Sciences Inc. plans to settle $13,548.39 in outstanding consulting debt by issuing 75,268 common shares. The company, which specializes in oral stimulant pouches, set the issuance price at $0.18 per share, with the transaction expected to finalize by September 30, 2026, pending regulatory approval.
Ello is abandoning the pressure of the perfectly curated family meal in favor of the messy, spontaneous reality of domestic life. The brand’s debut campaign, "Keep It Fresh," launching this month across digital and social channels, aims to reposition its food storage and hydration gear as tools for everyday improvisation.
An FDA advisory committee has voted in favor of the Galleri multi-cancer early detection test, marking a significant step toward potential regulatory approval. The panel concluded that the benefits of the test, which identifies cancer-specific methylation patterns in adults aged 50 and older, outweigh its associated risks.
A securities class action lawsuit now challenges DNOW Inc.’s acquisition of MRC Global, alleging that management concealed critical software failures to secure shareholder approval. Investors who held stock during the 2025 merger now face significant losses following a post-acquisition stock collapse linked to systemic ERP integration issues.
Investors who held Pentair plc stock between March 2025 and July 2026 now have until October 2, 2026, to seek lead plaintiff status in an expanded class action lawsuit. The litigation follows a sharp 15% stock decline triggered by a massive revenue miss and the sudden resignation of the company's CFO.
Seventy-six percent of fleet operators now cite direct economic savings as the primary driver for adopting electric terminal tractors, signaling a shift away from sustainability-only mandates. According to a new report from the North American Council for Freight Efficiency, the yard has transitioned into a proven proving ground for full-scale electrification.
Investors who held Alibaba Group Holding Limited stock between June 2025 and June 2026 are facing a critical deadline to join a class action lawsuit. Hagens Berman Sobol Shapiro LLP has initiated litigation in the Southern District of New York, alleging that the company misled shareholders regarding its regulatory standing and AI practices.
Investors who purchased Better Home & Finance Holding Company securities between March 13 and May 7, 2026, face a class action lawsuit filed by Robbins LLP. The litigation alleges the firm misled shareholders regarding its business trajectory, specifically failing to disclose significant headwinds impacting loan volume targets.
Investors who bought Aardvark Therapeutics stock between February 2025 and May 2026 are being urged to contact Hagens Berman Sobol Shapiro LLP. A newly filed securities class action alleges the biopharmaceutical firm misled shareholders regarding the safety and clinical viability of its flagship drug candidate, ARD-101.
Octane Rent is expanding its SUV fleet in Abu Dhabi, targeting the capital’s surging business and tourism sectors. The move integrates the city into the company’s broader network of over 400 vehicles, focusing on a tiered pricing model that ranges from mid-size cruisers to high-end luxury configurations.
A 34% single-day share price collapse on August 6, 2026, has triggered a securities class action lawsuit against UWM Holdings Corporation. Investors allege the company failed to disclose the true risks of a $603 million hedging loss stemming from a collapsed acquisition bid for Two Harbors Investment Corp.
The global flow cytometry market is set to nearly double over the next decade, growing from a valuation of $5.13 billion in 2025 to $11.14 billion by 2034. A new report from Maximize Market Research attributes this 9% compound annual growth rate to surging demand for high-parameter cell analysis in clinical diagnostics and oncology.
Investors who purchased Fractyl Health, Inc. stock before January 13, 2025, are being urged to contact Kuehn Law, PLLC. The firm has launched an investigation into potential breaches of fiduciary duty by the company’s officers and directors, centering on claims that the firm misled shareholders regarding its flagship therapy, Revita.
The global market for vitiligo treatments is poised for steady expansion, with valuations expected to climb from $1.79 billion in 2025 to $2.97 billion by 2034. This growth, projected at a compound annual rate of 5.8%, reflects a shift toward advanced targeted therapies and heightened aesthetic consciousness.
Two decades after Leo Gerard and Carl Pope bridged the divide between industrial labor and environmental advocacy, the BlueGreen Alliance convened in New York during Climate Week to evaluate the coalition's impact on national policy and the persistent challenge of securing union-backed green jobs in an era of economic uncertainty.
Shareholders of Flotek Industries are under scrutiny by Kuehn Law, PLLC, following allegations that company leadership breached fiduciary duties. The investigation centers on claims that executives misled investors regarding the financial stability and operational capacity of partners involved in a critical power generation project for the Puerto Rico Power Authority.
Priced at $8.99 in most corporate locations and $9.99 in California, Corner Bakery Cafe’s new Choose 2 promotion allows diners to pair two menu items with a side. The limited-time offer aims to balance the demand for affordability with the brand’s signature portion sizes through December 31, 2026.
A Dallas County jury has cleared pilot Daniel Filer of negligence following the 2023 crash of a Soviet-era MiG-23 jet, awarding him $1.725 million in damages. The verdict concludes a legal battle over an unauthorized ejection during the Thunder Over Michigan airshow that left the aircraft unmanned before it struck ground.
